EUVIMEDEUVIMED entdecken
Crossref

Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach

Iffat Jamal

Carcinogenesis and Chemotherapy · 2023

DOI: 10.31579/2835-9216/011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis and Chemotherapy, 2023. Verfasst von Iffat Jamal.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric chronic myeloid leukaemia (CML) is relatively uncommon. Lacking strong clinical study evidence, therapy of CML in children is not standardised and frequently adheres to recommendations made for adults. The clinical presentation of adolescents and young adults is typically more aggressive than that of older individuals, and prognostic ratings for adult CML do not apply to children.

Zitieren

APA

Jamal, I. (2023). Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach. Carcinogenesis and Chemotherapy. https://doi.org/10.31579/2835-9216/011

Vancouver

Jamal I. Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach. Carcinogenesis and Chemotherapy. 2023. doi:10.31579/2835-9216/011

BibTeX
@article{Jamal2023,
  author = {Jamal, Iffat},
  title = {Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach},
  journal = {Carcinogenesis and Chemotherapy},
  year = {2023},
  doi = {10.31579/2835-9216/011}
}
Kostenlos starten →